Form 4: X4 Pharmaceuticals Director Michael S. Wyzga Receives Stock Award

Michael S. Wyzga, a director at X4 Pharmaceuticals, acquired 45,000 shares of common stock through a restricted stock unit (RSU) grant.

Summary

• Michael S. Wyzga, a director of X4 Pharmaceuticals, received 45,000 shares of common stock on June 10, 2024.
• These shares were granted as restricted stock units (RSUs) as an annual award for service on the Board of Directors.
• The RSUs will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders, subject to continued board service through the applicable vesting date.
• The RSUs will also vest in full upon the occurrence of a change in control of the Issuer.
• Following the transaction, Wyzga beneficially owns 121,667 shares of X4 Pharmaceuticals.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (RSU grant) for a company director, indicating standard corporate governance practices. It's a neutral to slightly positive event as it aligns director interests with shareholders.

Positives

• The RSU grant aligns the director's interests with those of the shareholders.
• The vesting conditions incentivize continued service and commitment to the company's success.

Future Outlook

The vesting of the RSUs is contingent upon continued board service or a change in control of the Issuer.

Industry Context

This is a standard practice for compensating board members in publicly traded companies, aligning their interests with shareholders.

Comparison to Industry Standards

• RSU grants are a common form of equity compensation for directors in the pharmaceutical industry.
• The vesting schedule is typical, with vesting tied to continued service or a change in control, similar to practices at companies like BioCryst Pharmaceuticals and Global Blood Therapeutics before its acquisition.

Stakeholder Impact

• The RSU grant aligns the director's interests with those of the shareholders, incentivizing value creation.

Key Dates